{
  "ticker": "JNJ",
  "target_date": "2025-05-22",
  "actual_date": "2025-05-22",
  "collected_at": "2025-12-08T11:47:52.156146",
  "price": {
    "open": 149.3,
    "high": 149.96,
    "low": 148.05,
    "close": 149.26255798339844,
    "volume": 7535300,
    "change_1d_pct": -0.37,
    "change_7d_pct": 2.81,
    "change_30d_pct": 1.09
  },
  "technicals": {
    "rsi_14": 42.62,
    "sma_20": 150.19,
    "sma_50": 152.78,
    "macd": -1.151,
    "macd_signal": -1.319,
    "macd_histogram": 0.168,
    "bb_upper": 155.64,
    "bb_lower": 144.74,
    "price_vs_sma20_pct": -0.62,
    "price_vs_sma50_pct": -2.3,
    "volume_ratio": 0.95
  },
  "fundamentals": {
    "market_cap": 489219391488,
    "pe_ratio": 19.599903,
    "forward_pe": 19.15613,
    "price_to_book": 6.16308,
    "price_to_sales": 5.309004,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.29,
    "pct_from_52w_low": 44.34
  },
  "macro": {
    "spy": {
      "price": 579.76,
      "change_1d_pct": 0.04,
      "change_7d_pct": -0.77
    },
    "vix": {
      "level": 20.28,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.55
    },
    "dollar_index": {
      "level": 99.96
    },
    "gold": {
      "price": 3292.3
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors",
      "source": "Yahoo",
      "datetime": 1747950304,
      "summary": "In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.51, denoting a -0.44% change from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=9bfe89389c221cbdb77653f09cc22dfe884148def3eadc75e6ac5c29551ad104"
    },
    {
      "headline": "Johnson & Johnson : showcases latest advancements in cancer innovation with more than 70 clinical and real-world studies at ASCO and EHA",
      "source": "Finnhub",
      "datetime": 1747934777,
      "summary": "RARITAN, N.J., May 22, 2025 - Johnson & Johnson announced today promising new data from its hematologic malignancies and solid tumor portfolio and pipeline will be presented at the 2025 American...",
      "url": "https://finnhub.io/api/news?id=4001f7a23412a2875b76e64b073fa2dc1ee9d9f05f14b6039e0a7031da9c17f1"
    },
    {
      "headline": "JNJ Down 6% in 3 Months: How to Play the Stock Amid Various Challenges",
      "source": "Yahoo",
      "datetime": 1747919220,
      "summary": "While J&J's Innovative Medicines segment is showing a growth trend, the MedTech unit's slowdown is a concern",
      "url": "https://finnhub.io/api/news?id=6c5c15163a3ac59f3e8e1f7dad6a21d50e719dc5a787a58b2ede1656a952c860"
    },
    {
      "headline": "CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success",
      "source": "Yahoo",
      "datetime": 1747917960,
      "summary": "CG Oncology stock surges 27% in a month following superior efficacy data from its phase III study of cretostimogene for a bladder cancer indication.",
      "url": "https://finnhub.io/api/news?id=e83f7945e0bc79c15190095fcd18216a5bbb4f6e3dd5d3bfd5f228a311692fe0"
    },
    {
      "headline": "BNY Mellon Global Equity Income Fund Q1 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1747917060,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=21122177dcf301c8a85b28db74c633dac60cf5d385c12b4c38dab38f5f17dfc1"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    },
    {
      "form": "8-K",
      "date": "2025-04-30",
      "description": "jnj-20250424.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/jnj-20250424.htm"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877468.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000138/xslF345X05/wk-form4_1745877468.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877247.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000135/xslF345X05/wk-form4_1745877247.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}